Security samples A pathology staff member swabbing the mouth of a foreign security guard for signs of Covid-19 at a private lab in Jalan Mega Mendung, Kuala Lumpur.
PETALING JAYA: It is only the new enrollment of patients for hydroxychloroquine treatment under the Covid-19 global trial that has been temporarily suspended, says the World Health Organisation (WHO) representative to Malaysia.
Dr Jacqueline Lo Ying-Ru, Head of Mission and WHO representative to Malaysia, Brunei and Singapore, clarified that patients who had previously enrolled under the trial would finish their hydroxychloroquine treatment.
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
